0001178913-17-002888.txt : 20171026 0001178913-17-002888.hdr.sgml : 20171026 20171026064519 ACCESSION NUMBER: 0001178913-17-002888 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20171026 DATE AS OF CHANGE: 20171026 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Intec Pharma Ltd. CENTRAL INDEX KEY: 0001638381 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88958 FILM NUMBER: 171154666 BUSINESS ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 BUSINESS PHONE: 97225864657 MAIL ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AYALIM MUTUAL FUNDS LTD CENTRAL INDEX KEY: 0001705142 IRS NUMBER: 510918741 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: HAMENOFIM 8 ST CITY: HERZLIYA STATE: L3 ZIP: 4612003 BUSINESS PHONE: 09-9576000 MAIL ADDRESS: STREET 1: HAMENOFIM 8 ST CITY: HERZLIYA STATE: L3 ZIP: 4612003 SC 13G 1 zk1720664.htm SC 13G


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
 
Under the Securities Exchange Act of 1934
(Amendment No. ________)*
 
INTEC PHARMA LTD
(Name of Issuer)
 
Ordinary Shares
(Title of Class of Securities)
 
M53644106
(CUSIP Number)
 
Dekel Kotler, Hamenofim 8 st. Herzliya, 972-54-4925237
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 
August 4, 2017
(Date of Event which Requires Filing of this Statement)
 
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Rule 13d-1(b)
☒    Rule 13d-1(c)
    Rule 13d-1(d)
 
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 

 
 
         
CUSIP No. M53644106
 
13G
 
Page 2 of 6 Pages
 
 
1.
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

AYALIM MUTUAL FUNDS LTD
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)    ☒
(b)    
3.
SEC USE ONLY
 
 
4.
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israel
NUMBER  OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5.
SOLE VOTING POWER
 
00,000
6.
SHARED VOTING POWER
 
753,159 Ordinary Shares
7.
SOLE DISPOSITIVE POWER
 
00,000
8.
SHARED DISPOSITIVE POWER
 
753,159 Ordinary Shares
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

753,159 Ordinary Shares
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)    
 
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

2.9%
12.
TYPE OF REPORTING PERSON (see instructions)

CO
 
 

 
CUSIP No. M53644106
 
13G
 
Page 3 of 6 Pages
 
Item 1.
 
 
(a)
Name of Issuer

INTEC PHARMA LTD
 
   
 
(b)
Address of Issuer’s Principal Executive Offices

Hartom Har Hotzvim 12, P.O.B 45219, Jerusalem 9777512
 
Item 2.
 
 
(a)
Name of Person Filing
 
Ayalim Mutual Funds Ltd.
 
   
 
(b)
Address of the Principal Office or, if none, residence
 
Hamenofim 8, Herzliya.
 
   
 
(c)
Citizenship

Israel
 
   
 
(d)
Title of Class of Securities
 
Ordinary Shares, NIS 0.01 par value per share (The "Ordinary Shares")
 
   
 
(e)
CUSIP Number
 
M53644106
 
Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
Not Applicable
 
 
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
 
     
 
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
 
     
 
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
 
     
 
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
 
     
 
(e)
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
 
     
 
(f)
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
 
     
 
(g)
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
 
     
 
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
     
 
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
 
     
 
(j)
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
 
     
 

CUSIP No. 000000000
 
13G
 
Page 4 of 6 Pages
 
Item 4.  Ownership.
 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
 
(a)
 
Amount beneficially owned: 753,159 Ordinary Shares are held by mutual funds, managed by the reporting person.
 
       
 
(b)
 
Percent of class:  2.9%
 
       
 
(c)
 
Number of shares as to which the person has:  
 
       
 
 
 
(i)
Sole power to vote or to direct the vote  00,000
 
       
 
 
 
(ii)
Shared power to vote or to direct the vote 753,159.
 
       
 
 
 
(iii)
Sole power to dispose or to direct the disposition of  00,000.
 
       
 
 
 
(iv)
Shared power to dispose or to direct the disposition of 753,159.
 
Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).
 
Item 5.  Ownership of Five Percent or Less of a Class.
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following     .
 
Instruction. Dissolution of a group requires a response to this item.
 
Item 6.  Ownership of More than Five Percent on Behalf of Another Person.
 
Not Applicable 
 
Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
 
Not Applicable 
 
Item 8.  Identification and Classification of Members of the Group.
 
Not Applicable 
 
Item 9.  Notice of Dissolution of Group.
 
Not Applicable
 

CUSIP No. 000000000
 
13G
 
Page 5 of 6 Pages
 
Item 10.  Certification.
 
 
(a)
 
The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):
 
       
 
 
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
       
 
(b)
 
The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):
 
       
 
 
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 

 
CUSIP No. 000000000
 
13G
 
Page 6 of 6 Pages
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
26/10/2017
  Date
 
 
Kobi Segev
   Signature
 
 
CEO
  Name/Title